Amgen, Inc. (AMGN)
432.42
-4.57
(-1.05%)
USD |
NASDAQ |
Aug 28, 16:00
431.99
-0.43
(-0.10%)
After-Hours: 20:00
Amgen Cash from Operations (Annual) : 9.958B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 9.958B |
| December 31, 2024 | 11.49B |
| December 31, 2023 | 8.471B |
| December 31, 2022 | 9.721B |
| December 31, 2021 | 9.261B |
| December 31, 2020 | 10.50B |
| December 31, 2019 | 9.15B |
| December 31, 2018 | 11.30B |
| December 31, 2017 | 11.18B |
| December 31, 2016 | 10.35B |
| December 31, 2015 | 9.731B |
| December 31, 2014 | 8.555B |
| December 31, 2013 | 6.291B |
| December 31, 2012 | 5.882B |
| December 31, 2011 | 5.119B |
| December 31, 2010 | 5.787B |
| December 31, 2009 | 6.336B |
| December 31, 2008 | 5.988B |
| December 31, 2007 | 5.401B |
| December 31, 2006 | 5.389B |
| Date | Value |
|---|---|
| December 31, 2005 | 4.911B |
| December 31, 2004 | 3.697B |
| December 31, 2003 | 3.567B |
| December 31, 2002 | 2.249B |
| December 31, 2001 | 1.480B |
| December 31, 2000 | 1.635B |
| December 31, 1999 | 1.075B |
| December 31, 1998 | 1.042B |
| December 31, 1997 | 902.90M |
| December 31, 1996 | 822.60M |
| December 31, 1995 | 773.20M |
| December 31, 1994 | 531.89M |
| December 31, 1993 | 433.01M |
| December 31, 1992 | 292.80M |
| December 31, 1991 | 219.72M |
| March 31, 1991 | |
| March 31, 1990 | 18.69M |
| March 31, 1989 | -5.85M |
| March 31, 1988 | 6.414M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Gilead Sciences, Inc. | 10.02B |
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| AbbVie, Inc. | 19.03B |
| Biogen, Inc. | 2.205B |
| Vertex Pharmaceuticals, Inc. | 3.631B |